WO2004112711A3
(en )
2005-05-19
Oral extended-release composition
NO20053077L
(no )
2005-09-22
Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
WO1999043286A3
(en )
1999-12-02
Isolated stromal cells for use in the treatment of diseases of the central nervous system
TW200806318A
(en )
2008-02-01
Uses of anti-insulin-like growth factor I receptor antibodies
UA81390C2
(en )
2008-01-10
Use of unrestricted somatic stem cells (ussc) for the preparation of medicinal agents
UA95954C2
(ru )
2011-09-26
Продолжительное 24-часовое введение в кишечник леводопа/карбидопа
IL133585A0
(en )
2001-04-30
Soluble prodrugs of paclitaxel
PL1819227T3
(pl )
2011-07-29
Preparat farmaceutyczny decytabiny
MXPA05012810A
(es )
2006-02-13
Formas de dosis oral de memantina.
IL173481A0
(en )
2006-06-11
Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
ATE298324T1
(de )
2005-07-15
Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2001038303A3
(fr )
2002-01-17
Analogues de la vitamine d
NO20062355L
(no )
2006-05-23
Sammensetninger for behandling av sykdom i munnhulen og ovre andedrettssystem
BG106155A
(en )
2002-08-30
Novel derivatives and analogues of galanthamin
IL153288A0
(en )
2003-07-06
Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
BR0015149A
(pt )
2002-10-29
Método e composições para administração de taxanos oralmente a pacientes humanos
MD2355F1
(ro )
2004-01-31
Metoda de pregatire preimplantare
MX2008001520A
(es )
2008-04-07
Composiciones de tizanidina y metodos de tratamiento usando las composiciones.
WO2002094199A3
(en )
2003-12-24
METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
HUP0101514A2
(hu )
2001-11-28
Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával
MD2211F1
(ro )
2003-07-31
Remediu pentru tratamentul afectiunilor periodontiului
ATE408670T1
(de )
2008-10-15
Autologous selbst-toleranz induzierende zellen monozytären ursprungs und ihren verwendung in artzneimitteln
ATE293445T1
(de )
2005-05-15
Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
ATE425741T1
(de )
2009-04-15
Arzneizubereitung und deren anwendung zur behandlung von erkrankungen des inneren ohres
MD3885F1
(ro )
2009-04-30
Metoda de tratament complex al poliparazitozelor la bovine